Loss of the lipoprotein lipase activating ability of rat serum after administration of some fatty liver inducing drugs.

The effects of the administration of different fatty liver inducing drugs on the serum lipoprotein lipase activating ability was investigated in rats. Addition of serum from 2-mercaptoethanol-, 2-mercaptoacetate-, ethionine- or D-galactosamine- treated rats failed to activate heart and adipose tissue lipoprotein lipase from control rats. The activating effect of serum was only slightly reduced in isopropanol-treated rats, whereas it was found unaffected in ethanol-treated ones. Electrophoresis of the lipoproteins and of the very low density lipoproteins (VLDL) fraction of sera from 2-mercaptoethanol-, 2-mercaptoacetate-, isopropanol-, ethionine- and D-galactosamine-treated rats suggest that the lack of lipoprotein lipase activation ability of these sera is most probably related to the impairing effects of these drugs upon VLDL metabolism, i.e. reduction of VLDL secretion in the case of 2-mercaptoethanol, 2-mercaptoacetate and isopropanol, production of abnormal VLDL in the case of D-galactosamine and both decreased VLDL secretion and production of abnormal VLDL in the case of ethionine.

[1]  T. T. Jones,et al.  2-Mercaptoethanol as a substrate for liver alcohol dehydrogenase. , 1977, Archives of biochemistry and biophysics.

[2]  S. Eisenberg,et al.  Very low density lipoprotein: Dissociation of apolipoprotein C during lipoprotein lipase induced lipolysis , 1977 .

[3]  S. Sabesin,et al.  D-galactosamine hepatotoxicity. IV. Further studies of the pathogenesis of fatty liver. , 1976, Experimental and molecular pathology.

[4]  Y. Giudicelli,et al.  Is fatty liver induction a general feature of the administration of foreign sulfhydryl compounds? , 1976, Biochimica et biophysica acta.

[5]  P. Nilsson-ehle,et al.  Effects of apolipoproteins on lipoprotein lipase activity of human adipose tissue. , 1975, Clinica chimica acta; international journal of clinical chemistry.

[6]  C. Lieber.  Hepatic and metabolic effects of alcohol (1966 to 1973). , 1973, Gastroenterology.

[7]  Y. Giudicelli,et al.  Studies on the mechanisms involved in the isopropanol-induced fatty liver. , 1973, Biochimica et biophysica acta.

[8]  R. Krauss,et al.  Further Observations on the Activation and Inhibition of Lipoprotein Lipase by Apolipoproteins , 1973, Circulation research.

[9]  H. Tani,et al.  Effect of ethionine on carbohydrate and lipid metabolism. , 1973, Journal of lipid research.

[10]  S. Sabesin,et al.  D-Galactosamine Hepatitis I. Hepatocellular Injury and Fatty Liver Following A Single Dose , 1971 .

[11]  J. Larosa,et al.  A specific apoprotein activator for lipoprotein lipase. , 1970, Biochemical and biophysical research communications.

[12]  U. Rydberg,et al.  Inhibition of ethanol metabolism in vivo by administration of pyrazole. , 1969, Biochemical pharmacology.

[13]  R. P. Noble.  Electrophoretic separation of plasma lipoproteins in agarose gel. , 1968, Journal of lipid research.

[14]  E Farber,et al.  Ethionine fatty liver. , 1967, Advances in lipid research.

[15]  D. Williams,et al.  The enzymic reduction of nicotinamide-adenine dinucleotide by 2-mercaptoethanol. , 1965, The Biochemical journal.

[16]  D. Robinson,et al.  RELEASE OF CLEARING FACTOR LIPASE BY THE PERFUSED RAT HEART. , 1965, Journal of lipid research.

[17]  J. Brachet,et al.  Quelques effets biochimiques du β-mercaptoéthanol sur le foie de souris et de rat , 1961 .

[18]  K. Isselbacher,et al.  Studies on the pathogenesis of the ethanol-induced fatty liver. I. Synthesis and oxidation of fatty acids by the liver. , 1961, The Journal of clinical investigation.